选择性眼动脉注射使用气球导管用于视网膜母细胞瘤:一个七年临床评估
Sota Oguro1, Yi Ning Chen1, Takashi Yamane2
1Department of Ophthalmic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Japanese journal of ophthalmology
|June 4, 2024
概括
使用微气球导管进行选择性眼动脉注射 (SOAI) 是对视网膜母细胞瘤的一种安全有效的治疗方法. 这种方法在治疗这种眼睛癌症方面取得了99.2%的成功率.
科学领域:
- 眼科医生 眼科 眼科
- 干预性放射学 干预性放射学
- 儿科瘤学 儿科瘤学
背景情况:
- 视网母细胞瘤是一种常见的儿科眼癌.
- 动脉内化疗是一种向治疗方法.
- 选择性眼动脉注射 (SOAI) 提供局部药物输送.
研究的目的:
- 评估SOAI对视网膜母细胞瘤的有效性和安全性.
- 为了评估一个微气球导管系统与M室SOAI.
- 确定SOAI作为视网膜母细胞瘤的动脉内化疗的可行性.
主要方法:
- 125名视网膜母细胞瘤患者的回顾性分析 (2015年7月 - 2021年12月).
- 使用微气球导管系统与SOAI的M腔室.
- 梅尔法兰在确认眼动脉可视化和内动脉气球封闭后手动给药.
主要成果:
- 取得了99.2%的程序成功率.
- 平均手术持续时间为18.3分钟.
- 最少的不良事件:0.8%的支气管,0.4%的严重轨道炎症.
结论:
- 使用微气球导管系统的SOAI对于视网膜母细胞瘤治疗是可行的和安全的.
- 该系统的成功率很高 (99.2%).
- 建议使用SOAI作为视网膜母细胞瘤的动脉内化疗.
相关概念视频
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K


